(2025). Corrigendum to “Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”. Dermatology Research and Practice.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Corrigendum to “Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”."
Dermatology Research and Practice 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Corrigendum to “Effectiveness and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials”."
Dermatology Research and Practice, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.